SILDENAFIL Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Sildenafil, and what generic alternatives are available?
Sildenafil is a drug marketed by Ajanta Pharma Ltd, Alkem Labs Ltd, Amneal Pharms, Aurobindo Pharma Ltd, Chartwell Rx, Granules, Hetero Labs Ltd V, Invagen Pharms, Lupin, MSN, Novitium Pharma, Taro, Teva Pharms Usa, Tris Pharma Inc, Zydus Lifesciences, Eugia Pharma, Actavis Grp Ptc, Amneal Pharms Ny, Apotex Corp, Appco, Cadila Pharms Ltd, Jubilant Generics, Macleods Pharms Ltd, Mylan, Mylan Pharms Inc, Perrigo R And D, Reyoung, Rubicon Research, Sunshine, Teva, Teva Pharms, Torrent, Torrent Pharms Ltd, Umedica, and Watson Labs Inc. and is included in forty-nine NDAs.
The generic ingredient in SILDENAFIL is sildenafil citrate. There are twenty drug master file entries for this compound. Sixty-five suppliers are listed for this compound. Additional details are available on the sildenafil citrate profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Sildenafil
A generic version of SILDENAFIL was approved as sildenafil citrate by CHARTWELL RX on November 6th, 2012.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for SILDENAFIL?
- What are the global sales for SILDENAFIL?
- What is Average Wholesale Price for SILDENAFIL?
Summary for SILDENAFIL
| US Patents: | 0 |
| Applicants: | 35 |
| NDAs: | 49 |
| Drug Prices: | Drug price information for SILDENAFIL |
| Drug Sales Revenues: | Drug sales revenues for SILDENAFIL |
| What excipients (inactive ingredients) are in SILDENAFIL? | SILDENAFIL excipients list |
| DailyMed Link: | SILDENAFIL at DailyMed |
US Patents and Regulatory Information for SILDENAFIL
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Teva | SILDENAFIL CITRATE | sildenafil citrate | TABLET;ORAL | 077342-001 | Mar 9, 2016 | AB | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | |||
| Hetero Labs Ltd V | SILDENAFIL CITRATE | sildenafil citrate | TABLET;ORAL | 203623-001 | Nov 26, 2014 | AB | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | |||
| Aurobindo Pharma Ltd | SILDENAFIL CITRATE | sildenafil citrate | TABLET;ORAL | 203962-002 | Jun 11, 2018 | AB | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | |||
| Watson Labs Inc | SILDENAFIL CITRATE | sildenafil citrate | TABLET;ORAL | 202506-003 | Nov 25, 2020 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
